Please try another search
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Name | Age | Since | Title |
---|---|---|---|
Stacy A. Coen | 53 | 2021 | Independent Director |
S. Thomas Carmichael | - | - | Scientific Advisory Board Member |
Robert E. Hoffman | 58 | 2021 | Independent Director |
Neil A. Bhowmick | 53 | - | Scientific Advisory Board Member |
Victoria Niklas | 64 | 2021 | Independent Director |
Richard C. Cilento | 61 | 2021 | Independent Director |
Claudia F. Lucchinetti | - | - | Scientific Advisory Board Member |
Kate Rubins | - | - | Scientific Advisory Board Member |
Matthew W. Link | 49 | 2021 | Independent Director |
Peter O’Heeron | 60 | 2021 | Founder, Chairman & CEO |
Elizabeth J. Shpall | - | - | Scientific Advisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review